Evidence map›Paper›PMID 25787252›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in chronic lymphocytic leukemia.

James S Blachly, Amy S Ruppert, Weiqiang Zhao, Susan Long, Joseph Flynn, Ian Flinn, Jeffrey Jones, Kami Maddocks, Leslie Andritsos, Emanuela M Ghia and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Recovery of Immunoglobulin VJ Recombinations from Pancreatic Cancer Exome Files Strongly Correlates with Reduced Survival.Cancer microenvironment : official journal of the International Cancer Microenvironment Society · 2018
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

James S BlachlyDivision of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH 43210;
Amy S RuppertDivision of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH 43210;
Weiqiang ZhaoDepartment of Pathology, The Ohio State University, Columbus, OH 43210;
Susan LongDepartment of Pathology, The Ohio State University, Columbus, OH 43210;
Joseph FlynnDivision of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH 43210;
Ian FlinnHematologic Malignancies Research Program, Sarah Cannon Research Institute, Nashville, TN 37203;
Jeffrey JonesDivision of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH 43210;
Kami MaddocksDivision of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH 43210;
Leslie AndritsosDivision of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH 43210;
Emanuela M GhiaMoores Cancer Center, University of California at San Diego, La Jolla, CA 92092-0820;
Laura Z RassentiMoores Cancer Center, University of California at San Diego, La Jolla, CA 92092-0820;
Thomas J KippsMoores Cancer Center, University of California at San Diego, La Jolla, CA 92092-0820;
Albert de la ChapelleDepartment of Molecular Virology, Immunology, and Medical Genetics, The Ohio State University, Columbus, OH 43210; and Albert.delaChapelle@osumc.edu john.byrd@osumc.edu.
John C ByrdDivision of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH 43210; College of Pharmacy, The Ohio State University, Columbus, OH 43210 Albert.delaChapelle@osumc.edu john.byrd@osumc.edu.
The Ohio State University · USUniversity of California, San Diego · USMoores Cancer CenterSarah Cannon · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
Tissue CoreP01CA081534 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KIPPS, THOMAS J · 2000 to 2016
$59.5M
TWO SIGNAL REQUIREMENT FOR NATURAL KILLER IMMUNITYP01CA095426 · NCI · OHIO STATE UNIVERSITY · PI CALIGIURI, MICHAEL A · 2002 to 2016
$29.6M
PathologyP01CA101956 · NCI · OHIO STATE UNIVERSITY · PI BYRD, JOHN C. · 2006 to 2010
$11.4M
SPORE Leukemia Tissue BankP50CA140158 · NCI · OHIO STATE UNIVERSITY · PI BLOOMFIELD, CLARA D · 2009 to 2013
$11.2M
Targeted Therapy for Lymphoid MalignanciesR01CA177292 · NCI · OHIO STATE UNIVERSITY · PI ROGERS, KERRY ANNE, WOYACH, JENNIFER A. · 2013 to 2025
$5.3M
NCI NIH HHS P01 CA081534NCI NIH HHS P01 CA095426NCI NIH HHS P01 CA101956NCI NIH HHS P01 CA81534NCI NIH HHS P01 CA95426NCI NIH HHS P30 CA016058NCI NIH HHS P50 CA140158NCI NIH HHS R01 CA177292
6 · The paper itself

Abstract

Immunoglobulins (Ig) are produced by B lymphocytes as secreted antibodies or as part of the B-cell receptor. There is tremendous diversity of potential Ig transcripts (>1 × 10(12)) as a result of hundreds of germ-line gene segments, random nucleotide incorporation during joining of gene segments into a complete transcript, and the process of somatic hypermutation at individual nucleotides. This recombination and mutation process takes place in the maturing B cell and is responsible for the diversity of potential epitope recognition. Cancers arising from mature B cells are characterized by clonal production of Ig heavy (IGH@) and light chain transcripts, although whether the sequence has undergone somatic hypermutation is dependent on the maturation stage at which the neoplastic clone arose. Chronic lymphocytic leukemia (CLL) is the most common leukemia in adults and arises from a mature B cell with either mutated or unmutated IGH@ transcripts, the latter having worse prognosis and the assessment of which is routinely performed in the clinic. Currently, IGHV mutation status is assessed by Sanger sequencing and comparing the transcript to known germ-line genes. In this paper, we demonstrate that complete IGH@ V-D-J sequences can be computed from unselected RNA-seq reads with results equal or superior to the clinical procedure: in the only discordant case, the clinical transcript was out-of-frame. Therefore, a single RNA-seq assay can simultaneously yield gene expression profile, SNP and mutation information, as well as IGHV mutation status, and may one day be performed as a general test to capture multidimensional clinically relevant data in CLL.

Indexed as

Somatic Hypermutation, ImmunoglobulinAllelesBase SequenceComplementarity Determining RegionsGenomeHumansImmunoglobulinsImmunoglobulin Variable RegionLeukemia, Lymphocytic, Chronic, B-CellMolecular Sequence DataPolymerase Chain ReactionPrognosisSequence Analysis, RNASequence Homology, Nucleic AcidTranscriptomeVDJ RecombinasesComplementarity Determining RegionsImmunoglobulinsImmunoglobulin Variable RegionVDJ RecombinasesB cellsCLLimmunoglobulinRNA sequencingsomatic hypermutation

Identifiers

PMID25787252
PMCPMC4394264
OpenAlexW2000509813

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.